Skip to main content
Alan Ho on Muck Rack

Alan Ho

As seen in: Nature, Wiley Online Library, Clinical Rehabilitation, BMJ Oncology, The BMJ, ZDNet, The Lancet, HemOnc Today, SD Times, The New Stack and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alan

Contact Alan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tu1659 INSIGHTS FROM REAL-WORLD DOSING PATTERNS AND OUTCOMES OF HIGH DOSE UPADACITINIB IN SEVERELY REFRACTORY CROHN’S DISEASE

|
By Sarah Abushamma, Alan Ho, Siobhan Proksell
| Gastrointestinal Endoscopy Verified
Also available on ScienceDirect
Open in Who Shared Issue with article?

Scaffold-assisted window junctions for superconducting qubit fabrication

|
By Yen-Chun Chen, Zhen-Wei Xu, Matthew Snyder, Peng-Sheng Chen, Zihao Yang, Alan Ho, Robert McDermott, John Martinis, Chung-Ting Ke, Jun-Yi Tsai, Elam Blackwell, Spencer Weeden, Chih-Ming Lai, Shyh-Shyuan Sheu, Cen-Shawn Wu, Chii-Dong Chen
| Nature Verified
Abstract The superconducting qubit is one of the promising directions in realizing fault-tolerant quantum computing (FTQC), which requires many high-quality qubits. To achieve this, it is desirable to leverage modern semiconductor industry technology to ensure quality, uniformity, and reproducibility. However, conventional Josephson junction fabrication relies mainly on resist-assisted double-angle evaporation, posing integration challenges.
Open in Who Shared Issue with article?

Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control study

|
By Amir H. Safavi, Sean McBride, Alan Ho
| The Lancet Verified
Keywords Nasopharyngeal carcinoma Intensity-modulated proton therapy Intensity-modulated radiotherapy Toxicity Prognosis Evidence before this study Intensity-modulated proton therapy (IMPT), as the most advanced form of proton beam radiotherapy, may achieve superior overall survival and dosimetry to nearby organs-at-risk compared to intensity-modulated radiotherapy. Nonetheless, limited long-term follow-up data limits understanding of comparative late toxicity outcomes following IMPT.
Open in Who Shared Issue with article?
See all 113 licensed articles (118 Total)